About Archimedis Laboratories Private Limited
Data last updated:
Archimedis Laboratories Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 December 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2004PTC044970. Its GSTIN is 36AAFCA0358R1ZA (Telangana). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹9 Cr and a paid-up capital of ₹7.01 Cr. It is led by directors Venkateswara Reddy Maddireddy and Kesava Reddy Maddireddy.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹114.19 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹12.07 Cr (net margin 10.6%) and EBITDA of ₹27.98 Cr (EBITDA margin 24.5%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 5% over five years.
The company has about 87 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹67.67 Cr and satisfied charges of ₹28.84 Cr on record. Court records list 5 cases involving the company, including 4 filed by the company and 1 filed against it; 2 cases are pending. The company has 7 deals on record (6 funding rounds, 1 secondary share transfer), with disclosed funding of ₹6.65 Cr; the latest was in October 2017. Its 8 peer companies in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Prachem Laboratories Private Limited with revenue of ₹117.4 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website archimedislabs.org.
Company details
CIN history
Archimedis Laboratories has one previous CIN (Corporate Identification Number): U24239AP2004PTC044970. The current CIN is U24239TG2004PTC044970, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2004PTC044970 | Current |
| U24239AP2004PTC044970 | Previous |
Contact details
Archimedis Laboratories Private Limited's registered office is in Hyderabad, Telangana. Its website is archimedislabs.org. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressH.No.5 – 163/1 2nd Floor Malleshwari Nilayam Chintalkunta L B Nag, Ar Post, Hyderabad, Telangana, India – 500074
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Archimedis Laboratories Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Archimedis Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Archimedis Laboratories Private Limited, buy the company report.
Financials of Archimedis Laboratories Private Limited
FY 2024 filings availableArchimedis Laboratories Private Limited reported revenue of ₹114.19 Cr (up 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 22% growth in the latest year. EBITDA rose 275% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹27.98 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹12.07 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 24.5% | ||||
| Net Profit Margin | 10.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Archimedis Laboratories Private Limited, buy the company report.
Board of directors of Archimedis Laboratories Private Limited
Archimedis Laboratories has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkateswara Reddy Maddireddy Also directs: Vedadri Envirotech Foundation | Director | 24 Dec 2004 | 21 Years 10 Months | Current |
| Kesava Reddy Maddireddy | Director | 24 Dec 2004 | 21 Years 10 Months | Current |
Peer comparison
Archimedis Laboratories Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Prachem Laboratories Private Limited | ₹117.4 Cr (FY 2025) | -6.0% | Gandhinagar, Gujarat, India | |||
| Aastrid Life Sciences Private Limited | ₹115.25 Cr (FY 2025) | 6.0% | Navi Mumbai, Maharashtra, India | |||
| Element Chemilink Private Limited | ₹115.09 Cr (FY 2025) | 31.0% | Gujarat, India | |||
| Godavari Drugs Limited | ₹114.33 Cr (FY 2025) | -27.0% | Secunderabad, Telangana, India | |||
| Archimedis Laboratories Private Limitedthis company | ₹114.19 Cr (FY 2025) | ₹12.07 Cr | 10.6% | 22.0% | 87 | Hyderabad, Telangana, India |
| Glochem Industries Private Limited | ₹113.55 Cr (FY 2025) | -7.0% | Hyderabad, Telangana, India | |||
| Venkar Chemicals Private Limited | ₹112.58 Cr (FY 2024) | 61.0% | Hyderabad, Telangana, India | |||
| Bakul Pharma Private Limited | ₹110.31 Cr (FY 2025) | -21.0% | Mumbai, Maharashtra, India | |||
| Danopharm Private Limited | ₹108.78 Cr (FY 2025) | -7.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Archimedis Laboratories Private Limited, buy the company report.
Auditor
Archimedis Laboratories Private Limited is audited by MSPR & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MSPR & CO | FY 2023 | 010152S |
Shareholding
The shareholding of Archimedis Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Archimedis Laboratories Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Mar 2025 | 101076419 | Others | ₹3.5 Cr | Open | |
| 20 Mar 2025 | 101062643 | Others | ₹8.42 Cr | Open | |
| 16 Jan 2025 | 101044543 | Others | ₹5 Cr | Open | |
| 27 Apr 2022 | 100581470 | Hdfc Bank Limited | ₹50.75 Cr | Open | |
| 31 Jan 2017 | 100084273 | Axis Bank Limited | ₹12.79 Cr | Satisfied |
To see the full charge records of Archimedis Laboratories Private Limited, buy the company report.
Total charge records: 10 View all charges
Deals & funding
Archimedis Laboratories Private Limited has 7 deals on record (6 funding rounds, 1 secondary share transfer), with disclosed funding of ₹6.65 Cr; the latest was in October 2017.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2017 | Funding round | ₹53.9 Lakh | Investors: 4 individuals |
| Mar 2017 | Funding round | ₹71.2 Lakh | Investors: an individual |
| Sep 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 4 individuals |
| Mar 2013 | Funding round | ₹1.65 Cr | Investors: 4 individuals |
| Nov 2011 | Funding round | ₹2.22 Cr | Investors: 4 individuals |
To see the full deal history of Archimedis Laboratories Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Archimedis Laboratories Private Limited has 5 court cases on record: 4 filed by Archimedis Laboratories, 1 filed against it. 2 cases are pending and 3 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 0 | 1 |
| Supreme Court | 1 | 1 | 1 |
Cases on record (4 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (1901-Energy Laws - Electricity, Petroleum, Oil and Natural Gas : Energy laws - Electricity, Petroleum, Oil and Natural Gas) | Filed against the company by The State of Andhra Pradesh | Pending |
| High Court for State of Telangana | Writ petition | Filed by the company against The Singareni Collieries Company Ltd., and 4 Others, and 3 others | Pending |
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Central Power Distribution Company of Andhra Pradesh Ltd. and 2 others | Disposed |
| High Court, TELANGANA | Writ petition | Filed by the company against State of Telangana and 2 others | Disposed |
To see the full case history of Archimedis Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Archimedis Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Archimedis Laboratories Private Limited has a workforce of 87 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
Archimedis Laboratories has 4 GST registrations: 2 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCA0358R1ZA | Telangana | Active | 01 Jul 2017 |
| 37AAFCA0358R2Z7 | Andhra Pradesh | Active | 19 Mar 2020 |
To see the full GST registrations and return filing status of Archimedis Laboratories Private Limited, buy the company report.
Recent activity
Archimedis Laboratories Private Limited has 3 board changes on record since 2004: 2 appointments and 1 cessation. The latest: Kurapati Koteswara Reddy ceased to be Director on 04 Sep 2015.
16 earlier events are in the company report.
Frequently asked questions
Archimedis Laboratories is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 December 2004 (22+ years old) and is registered under CIN U24239TG2004PTC044970.
Archimedis Laboratories has 2 current directors:
- Venkateswara Reddy Maddireddy - Director
- Kesava Reddy Maddireddy - Director
The latest financial statements of Archimedis Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Archimedis Laboratories is 36AAFCA0358R1ZA, registered in Telangana. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 37AAFCA0358R2Z7 (Andhra Pradesh).
The CIN (Corporate Identification Number) of Archimedis Laboratories is U24239TG2004PTC044970. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Archimedis Laboratories has 5 court cases on record: 4 filed by the company and 1 filed against it. 2 are pending. Most are in the high courts.
Archimedis Laboratories was incorporated on 24 December 2004, making it 22+ years old. It is registered with the Registrar of Companies, Hyderabad.
Archimedis Laboratories has 7 deals on record (6 funding rounds, 1 secondary share transfer), with disclosed funding of ₹6.65 Cr; the latest was in October 2017.
The peers of Archimedis Laboratories by revenue are Prachem Laboratories Private Limited, Aastrid Life Sciences Private Limited, Element Chemilink Private Limited, Godavari Drugs Limited, Glochem Industries Private Limited and 3 more, all in the Pharma industry (API Manufacturers), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Kurapati Koteswara Reddy ceased to be Director on 04 Sep 2015. Kesava Reddy Maddireddy was appointed as Director on 24 Dec 2004. Venkateswara Reddy Maddireddy was appointed as Director on 24 Dec 2004.
Archimedis Laboratories can be reached through the website archimedislabs.org. Its registered office is in Hyderabad, Telangana, India.